ELL Antikörper (C-Term)
Kurzübersicht für ELL Antikörper (C-Term) (ABIN952064)
Target
Alle ELL Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 523-553, C-Term
-
Spezifität
- This antibody recognizes ELL at C-term.
-
Kreuzreaktivität (Details)
- Species reactivity (tested):Human, Mouse
-
Aufreinigung
- Purified through a protein A column followed by peptide affinity purification
-
Immunogen
- Synthetic peptide - KLH conjugated - corresponding to the C-terminal region (between 523-553aa) of human ELL.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS with 0.09 % (W/V) Sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- ELL (Elongation Factor RNA Polymerase II (ELL))
-
Andere Bezeichnung
- ELL
-
Hintergrund
- Elongation factor that can increase the catalytic rate of RNA polymerase II transcription by suppressing transient pausing by the polymerase at multiple sites along the DNASynonyms: C19orf17, Eleven-nineteen lysine-rich leukemia protein, RNA polymerase II elongation factor ELL
-
Gen-ID
- 8178
-
NCBI Accession
- NP_006523
Target
-